Evidence map›Paper›PMID 32160132›Full record

ArticleCirculation research2020

PTH/PTHrP Receptor Signaling Restricts Arterial Fibrosis in Diabetic LDLR

Abraham Behrmann, Dalian Zhong, Li Li, Su-Li Cheng, Megan Mead, Bindu Ramachandran, Parastoo Sabaeifard, Mohammad Goodarzi, Andrew Lemoff, Henry M Kronenberg and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Sequence specificity defines the effectiveness of PPMOs targetingAntimicrobial agents and chemotherapy · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Abraham Behrmann *From the Internal Medicine, Endocrine Division (A.B., D.Z., L.L., S.-L.C., M.M., B.R., P.S., D.A.T.), UT Southwestern Medical Center, Dallas, TX.
Dalian Zhong *From the Internal Medicine, Endocrine Division (A.B., D.Z., L.L., S.-L.C., M.M., B.R., P.S., D.A.T.), UT Southwestern Medical Center, Dallas, TX.
Li Li *
Su-Li ChengFrom the Internal Medicine, Endocrine Division (A.B., D.Z., L.L., S.-L.C., M.M., B.R., P.S., D.A.T.), UT Southwestern Medical Center, Dallas, TX.
Megan MeadFrom the Internal Medicine, Endocrine Division (A.B., D.Z., L.L., S.-L.C., M.M., B.R., P.S., D.A.T.), UT Southwestern Medical Center, Dallas, TX.
Bindu RamachandranFrom the Internal Medicine, Endocrine Division (A.B., D.Z., L.L., S.-L.C., M.M., B.R., P.S., D.A.T.), UT Southwestern Medical Center, Dallas, TX.
Parastoo SabaeifardFrom the Internal Medicine, Endocrine Division (A.B., D.Z., L.L., S.-L.C., M.M., B.R., P.S., D.A.T.), UT Southwestern Medical Center, Dallas, TX.
Mohammad GoodarziBiochemistry (M.G., A.L.), UT Southwestern Medical Center, Dallas, TX.
Andrew LemoffBiochemistry (M.G., A.L.), UT Southwestern Medical Center, Dallas, TX.
Henry M KronenbergEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston (H.M.K.).
Dwight A TowlerFrom the Internal Medicine, Endocrine Division (A.B., D.Z., L.L., S.-L.C., M.M., B.R., P.S., D.A.T.), UT Southwestern Medical Center, Dallas, TX.
Southwestern Medical Center · USMassachusetts General Hospital · US

Funding

Tissue Phenotyping CoreP01DK011794 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BOUXSEIN, MARY L · 1986 to 2023
$44.4M
OSTEOGENIC REGULATION OF VASCULAR CALCIFICATIONR01HL069229 · NHLBI · WASHINGTON UNIVERSITY · PI TOWLER, DWIGHT A. · 2001 to 2022
$7.9M
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor SignaR01HL114806 · NHLBI · WASHINGTON UNIVERSITY · PI TOWLER, DWIGHT A. · 2012 to 2016
$2.1M
Cdc42bpg signaling in arteriosclerosis and vascular fibrosisR03TR004144 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOWLER, DWIGHT A. · 2022 to 2022
$164k
NCATS NIH HHS R03 TR004144NHLBI NIH HHS R01 HL069229NHLBI NIH HHS R01 HL114806NIDDK NIH HHS P01 DK011794
6 · The paper itself

Abstract

rationaleThe PTH1R (PTH [parathyroid hormone]/PTHrP [PTH-related protein] receptor) is expressed in vascular smooth muscle (VSM) and increased VSM PTH1R signaling mitigates diet-induced arteriosclerosis in LDLR

objectiveTo study the impact of VSM PTH1R deficiency, we generated mice SM22-Cre:PTH1R(fl/fl);LDLR METHODS AND

resultsImmunofluorescence and Western blot confirmed PTH1R expression in arterial VSM that was reduced by Cre-mediated knockout. PTH1R-VKO cohorts exhibited increased aortic collagen accumulation in vivo, and VSM cultures from PTH1R-VKO mice elaborated more collagen (2.5-fold;

conclusionsPTH1R signaling restricts collagen production in the VSM lineage, in part, via Mkl-1 regulatory circuits that control collagen gene transcription. Strategies that maintain homeostatic VSM PTH1R signaling, as reflected in extracellular vesicle biomarkers of VSM PTH1R/Mkl-1 action, may help mitigate arteriosclerosis and vascular fibrosis.

Indexed as

AnimalsAortaAtherosclerosisCells, CulturedCollagen Type ICollagen Type I, alpha 1 ChainCollagen Type IIIDiabetes MellitusDiet, High-FatDisease Models, AnimalFibrosisHumansMaleMice, Inbred C57BLMice, KnockoutMuscle, Smooth, VascularCOL3A1 protein, mouseCollagen Type ICollagen Type I, alpha 1 ChainCollagen Type IIIMrtfa protein, mouseParathyroid HormonePTH1R protein, mouseReceptor, Parathyroid Hormone, Type 1Receptors, LDLTrans-Activatorsarteriosclerosiscardiovascular diseasescollagenfibrosistranscription factors

Identifiers

PMID32160132
PMCPMC7524585
OpenAlexW3011832880

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.